OncoOne: Raises €13M in Series A Funding
- Austria-based OncoOne closed its Series A funding round with €13m raised
- This financing will used to officially launch the company and support the development of oncology treatments
- Then the initial funding will enable the company to develop its solutions to provide innovative treatments for cancer indications with poor prognosis
- Then the funding round was led by the Austrian Research Promotion Agency, the Austria Wirtschaftsservice Gesellschaft, and two family offices
- The FFG and AWS had previously invested in OncoOne back in August and November 2018
- OncoOne founded in June 2018 by Randolf Kerschbaumer, Michael Thiele and Alexander Schinagl